Gemin X Pharmaceuticals has closed an $8 million Series E round of funding that it will use to prepare for Phase 3 clinical trials of its lung cancer drug. The Malvern, Pennsylvania-based company is in the midst of a Phase 2b trial of its lead candidate, obatoclax, which is intended for the treatment of extensive-stage […]
Dr. A. Michael Lincoff is part of a new nine-member medical advisory board at Regado Biosciences, a New Jersey company developing a quickly reversible anti-clotting drugs to help with heart problems including acute coronary syndrome.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.